Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flecainide CR vs Placebo in Early AF
NCT00408473Phase 4Terminated
- Sponsor
- Meda
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 4 trial of flecainide in Atrial fibrillation (AFib), sponsored by Meda. Status: terminated.
02
Drugs
flecainide
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00408473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408473.